Microalgae, Cell Factories for Antimicrobial Peptides: A Promising Response to Antibiotic Resistance

Area of Science:

• Biotechnology
• Microbiology
• Drug Discovery

Background:

• Infectious disease prevalence is increasing, coupled with growing antibiotic resistance.
• Conventional antibiotics are becoming less effective, necessitating the development of novel antibacterial agents.
• Antimicrobial peptides (AMPs) present an alternative mechanism of action to combat resistant pathogens.

Purpose of the Study:

• To review the potential of microalgae as sustainable cell factories for antimicrobial peptide production.
• To examine the advantages and limitations of using microalgae in biopharmaceutical manufacturing.
• To explore microalgae as a solution to the challenge of antibiotic resistance.

Main Methods:

• Review of current literature on recombinant antimicrobial peptide production.
• Analysis of microalgae cultivation and genetic engineering techniques for biopharmaceutical synthesis.
• Evaluation of the efficiency and scalability of microalgae-based peptide production.

Main Results:

• Traditional chemical synthesis of antimicrobial peptides faces challenges with longer chains due to folding and purification complexities.
• Recombinant production in various cell factories has been established for AMPs.
• Microalgae demonstrate potential as cost-effective, easily cultivable platforms for sustainable AMP production.

Conclusions:

• Microalgae represent a promising, sustainable alternative for the biopharmaceutical production of antimicrobial peptides.
• This approach offers a viable strategy to address the escalating issue of antibiotic resistance.
• Further research into microalgae as cell factories could revolutionize biopharmaceutical manufacturing.